Core Insights - The company reported a significant decline in both revenue and net profit for the first half of 2025, with revenue at 2.349 billion yuan, down 26.5% year-on-year, and net profit at 455 million yuan, down 40.64% year-on-year [1] Company Overview - The company, Chuaning Biological, focuses on a dual-driven strategy of "biological fermentation" and "synthetic biology" [1] - It is primarily engaged in the research and industrialization of biological fermentation technology and synthetic biology products [1]